Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas [Phase 2]
This completed Phase 2 trial evaluated the combination of Zevalin with BEAM high-dose chemotherapy followed by autologous stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update showing completion of FR901228 (romidepsin) in relapsed or refractory Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating aminocamptothecin in patients with refractory or recurrent Hodgkin lymphoma or non-Hodgkin lymphoma has been comp…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 monoclonal antibody therapy trial for patients with recurrent Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Sorafenib in adults with recurrent non-Hodgkin lymphoma, including Anaplastic Large Cell Lymphoma, Diffuse Large B-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
FDA approval · 2013-02-05FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA's supplemental application for methotrexate, enabling the marketing of a generic methotrexate product…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial of a rebeccamycin analogue in pediatric patients with solid tumors or Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating flavopiridol in patients with recurrent intermediate- or high-grad…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial of Bryostatin-1 in patients with recurrent non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating pentostatin and rituximab in patients with low-grade non-Hodgkin lymphoma or chronic lymphocytic leukemia has compl…
-
FDA approval · 2013-02-04FDA Approved: DOXORUBICIN HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved a generic doxorubicin hydrochloride product under Original Application for BluePoint Laboratories (ANDA 203263). This marks app…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia [Phase 4]
Phase 4 multi-center trial ALL-REZ BFM 2002 for children with relapsed acute lymphoblastic leukemia has completed enrollment and status is c…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating interferon alfa plus thalidomide in relapsed or refractory non-Hodgkin lymphoma, specifically recurrent follicula…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study (S9911) evaluating the combination of chemotherapy plus monoclonal antibody therapy for patients with Non-Hodgkin lymphoma h…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluated oxaliplatin in patients with relapsed or refractory non-Hodgkin lymphoma across multiple subtypes and has complete…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SB-715992 in patients with metastatic or unresectable solid tumors and various Hodgkin's and non-Hodgkin's lymphomas has be…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating Bryostatin-1 in combination with vincristine for progressive or relapsed non-Hodgkin lymphoma after bone…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma [EARLY_Phase 1]
This early-phase clinical trial update describes a monoclonal antibody therapy combined with peripheral stem cell transplantation for patien…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating thalidomide in relapsed or refractory non-Hodgkin lymphoma has completed enrollment. The study included patients wi…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial in China evaluating survival outcomes for children and adolescents with non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Positron Emission Tomography(PET) in Lymphoma Assessment [NA]
Clinical trial update on PET imaging for Hodgkin lymphoma and Non-Hodgkin lymphoma assessment reports the study status as completed.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Ph II CHOP+Velcade in Mediastinal LBCL [Phase 2]
A Phase II trial of CHOP plus bortezomib (Velcade) for mediastinal large B-cell lymphoma, a form of non-Hodgkin lymphoma, was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologi…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease [Phase 1]
A Phase 1 clinical trial update describes giving gene-marked EBV-specific T-cells to patients receiving a bone marrow transplant for relapse…